AMRX R&D Expenses
Amneal Pharmaceuticals Inc Class A · R&D Expenses
AMRX R&D Expenses
Latest reported$177.66Mperiod ending
AMRX R&D Expenses ($106.74M → $177.66M)
Annual R&D Expenses
High-resolution chart · PNG
AMRX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 186,175,000 | |
| 190,714,000 | |
| 194,750,000 | |
| 208,658,000 | |
| 209,563,000 | |
| 190,585,000 | |
| 202,287,000 | |
| 210,451,000 | |
| 191,938,000 | |
| 204,747,000 | |
| 136,870,000 | |
| 106,735,000 |